The treatment of primary central nervous system lymphoma in 122 immunocompetent patients
暂无分享,去创建一个
R. Gascoyne | L. Sehn | J. Connors | T. Pickles | James W Morris | T. Shenkier | R. Klasa | P. Hoskins | M. Chhanabhai | S. O'Reilly | N. Voss | R. Fairey | James Morris
[1] E. Thiel,et al. Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan , 2004, Neurology.
[2] J. Armitage,et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] T. Batchelor,et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Blay,et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L. Deangelis,et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Blay,et al. A multicenter study of treatment of primary CNS lymphoma , 2002, Neurology.
[7] A. López-Guillermo,et al. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] K. Hoang-Xuan,et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] L. Deangelis,et al. Treatment for primary CNS lymphoma: the next step. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Dichgans,et al. PCV salvage chemotherapy for recurrent primary CNS lymphoma , 2000, Neurology.
[11] M. Barton,et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G Flandrin,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Y. Shibamoto,et al. Primary central nervous system lymphoma in Japan: a nationwide survey. , 1999, International journal of radiation oncology, biology, physics.
[15] M. Reni,et al. Second-line treatment for primary central nervous system lymphoma , 1999, British Journal of Cancer.
[16] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] J. Corry,et al. Primary central nervous system lymphoma: age and performance status are more important than treatment modality. , 1998, International journal of radiation oncology, biology, physics.
[18] J. Blay,et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] L. Deangelis,et al. Long-term survival in primary CNS lymphoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Reni,et al. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] J. O'fallon,et al. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? , 1995, International journal of radiation oncology, biology, physics.
[22] P. Burger,et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma , 1994, Neurology.
[23] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[25] J. Peto,et al. Asymptotically Efficient Rank Invariant Test Procedures , 1972 .
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .